Dr. Michael S. Calderwood, MD, MPH

Dr. Calderwood practices at Dartmouth Hitchcock Medical Center in Lebanon, New Hampshire, part of Dartmouth-Hitchcock Health.

Dr. Calderwood's NPI, 1982756664, was assigned on January 16, 2007. Dr. Calderwood graduated from University of Chicago, Pritzker School of Medicine in 2005. Dr. Calderwood holds New Hampshire license 17491.

Dr. Calderwood's primary practice is Dartmouth Hitchcock Medical Center, at 1 Medical Center Drive, Lebanon, NH 03756 in Grafton County. The practice phone is (603) 650-5000.

Dr. Calderwood's primary practice is Dartmouth Hitchcock Medical Center in Lebanon, New Hampshire, part of Dartmouth-Hitchcock Health. The medical group on file is Dartmouth Hitchcock Clinics Manchester. Dmand AI also links Dr. Calderwood to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Calderwood practices. Vendor and product names are available with a free account.

Infectious disease is Dr. Calderwood's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Calderwood is licensed in New Hampshire.

CMS data shows 146 Medicare services from Dr. Calderwood across 4 procedure codes in 2024, for 113 Medicare patients. Medicare paid $12,706 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 113 Medicare patients who saw Dr. Calderwood in 2024. The largest group is 65 to 74, with 52 patients. 75% of them have high blood pressure, and 67% have high cholesterol. 27% are also on Medicaid. Their average risk score is 2.50, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Calderwood's median patient age at 61, with 40% women.

In 2024, Dr. Calderwood wrote 203 Medicare Part D claims for 43 patients. 97% of them were for generic drugs. CMS names the drug for 129 of them, across 6 drugs with 11 or more claims each, at $4,675 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Calderwood for performance year 2024, reported through an alternative payment model (APM). Dr. Calderwood accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Calderwood as offering telehealth.

Dmand AI links 45 papers to Dr. Calderwood, published from 2011 to 2023. 2023 was the busiest year, with 9. The most frequent topics are Anti-Bacterial Agents, Hospitals and Cross Infection. Dr. Calderwood has published most often in Infect Control Hosp Epidemiol. Dr. Calderwood's most frequent co-authors are Justin J. Kim, MD, Edward J. Septimus, MD and Robert Alan Weinstein, MD.

Dr. Calderwood graduated from University of Chicago, Pritzker School of Medicine in 2005.